Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.09 is 184% below its 5-year average of -0.03, near the high end of its 5-year range (-6.73–2.18).
97.36% above its 12-month average of -3.41.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.06.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:27:09.740Z. Historical observations retain their original dates. Historical series through 2024-11-04.
EARNINGS PER SHARE (EPS)
-0.09
EARNINGS PER SHARE (EPS) AVG TTM
-3.41
EARNINGS PER SHARE (EPS) AVG 3Y
-0.94
EARNINGS PER SHARE (EPS) AVG 5Y
-0.03
EARNINGS PER SHARE (EPS) AVG 10Y
0.26
EARNINGS PER SHARE (EPS) AVG 15Y
0.72
EARNINGS PER SHARE (EPS) AVG 20Y
0.66
CURRENT VS TTM AVG
+97.36%
CURRENT VS 3Y AVG
+90.45%
CURRENT VS 5Y AVG
-183.91%
CURRENT VS 10Y AVG
-133.99%
CURRENT VS 15Y AVG
-112.53%
CURRENT VS 20Y AVG
-113.55%
Integra LifeSciences Holdings Corporation
Market Cap
$1.04B
Earnings Per Share (EPS)
-0.09
TTM Avg
-3.41
3Y Avg
-0.94
5Y Avg
-0.03
Market Cap
$1.04B
Earnings Per Share (EPS)
-0.66
TTM Avg
-0.08
3Y Avg
-1.22
5Y Avg
-1.11
Market Cap
$1.04B
Earnings Per Share (EPS)
-1.84
TTM Avg
-0.83
3Y Avg
-0.99
5Y Avg
-2.01
Market Cap
$1.04B
Earnings Per Share (EPS)
-1.64
TTM Avg
-1.56
3Y Avg
-1.49
5Y Avg
-1.15
Market Cap
$1.02B
Earnings Per Share (EPS)
-0.38
TTM Avg
-0.83
3Y Avg
-0.98
5Y Avg
-0.98
Market Cap
$1.05B
Earnings Per Share (EPS)
-0.99
TTM Avg
-3.50
3Y Avg
-23.24
5Y Avg
-16.84
Market Cap
$1.06B
Earnings Per Share (EPS)
-3.37
TTM Avg
-3.42
3Y Avg
-2.02
5Y Avg
-1.79
Market Cap
$1.00B
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$997.66M
Earnings Per Share (EPS)
-2.97
TTM Avg
-9.41
3Y Avg
-6.16
5Y Avg
-6.16
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corporation (IART) | $1.04B | -0.09 | -3.41 | -0.94 | -0.03 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | -0.66 | -0.08 | -1.22 | -1.11 |
| Immatics N.V. (IMTX)vs › | $1.04B | -1.84 | -0.83 | -0.99 | -2.01 |
| Janux Therapeutics, Inc. (JANX)vs › | $1.04B | -1.64 | -1.56 | -1.49 | -1.15 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | -0.38 | -0.83 | -0.98 | -0.98 |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -0.99 | -3.50 | -23.24 | -16.84 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.06B | -3.37 | -3.42 | -2.02 | -1.79 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $997.66M | -2.97 | -9.41 | -6.16 | -6.16 |
| MeiraGTx Holdings plc (MGTX)vs › | $991.32M | 0.71 | -1.77 | -1.98 | -1.86 |
Trailing EPS (TTM)
$-0.09
Forward EPS (Est.)
$2.44
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -6.73 |
| 2024-12-31 | -0.09 |
| 2023-12-31 | 0.87 |
| 2022-12-31 | 2.18 |
| 2021-12-31 | 2.00 |
| 2020-12-31 | 1.58 |
| 2019-12-31 | 0.59 |
| 2018-12-31 | 0.73 |
| 2017-12-31 | 0.83 |
| 2016-12-31 | 1.00 |
| 2015-12-31 | -0.05 |
| 2014-12-31 | 0.52 |
| 2013-12-31 | -0.30 |
| 2012-12-31 | 0.74 |
| 2011-12-31 | 0.52 |
| 2010-12-31 | 1.11 |
| 2009-12-31 | 0.88 |
| 2008-12-31 | 0.49 |
| 2007-12-31 | 0.61 |
| 2006-12-31 | 0.50 |
| 2005-12-31 | 0.62 |
| 2004-12-31 | 0.28 |
| 2003-12-31 | 0.46 |
| 2002-12-31 | 0.61 |
| 2001-12-31 | 0.54 |
| 2000-12-31 | -0.33 |
| 1999-12-31 | -0.18 |
| 1998-12-31 | -0.38 |
| 1997-12-31 | -0.58 |
| 1996-12-31 | -0.27 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T16:27:09.740Z. Historical observations retain their original dates. Historical series through 2024-11-04.
